AUPH FY 2008 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

AUPHAurinia Pharmaceuticals Inc.

$2B

FY 2008 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+66.1% YoY

Gross Profit

$2M45.4% margin

Operating Income

-$16M-422.0% margin

Net Income

-$16M-409.7% margin

EPS (Diluted)

$-7.47

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$18M

Stock-Based Comp.

$489,728

Balance Sheet

Total Assets

$27M

Total Liabilities

$19M

Stockholders' Equity

$8M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$2M	+66.1%
Gross Profit	$2M	$1M	+37.2%
Operating Income	-$16M	-$36M	+54.6%
Net Income	-$16M	-$34M	+53.0%